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Abstract
Background: Patient access to medicines at home during the last year of life is critical for symptom control, but is
thought to be problematic. Little is known about healthcare professionals’ practices in supporting timely medicines
access and what influences their effectiveness. The purpose of the study was to evaluate health professionals’
medicines access practices, perceived effectiveness and influencing factors.
Methods: On-line questionnaire survey of health care professionals (General Practitioners, Community Pharmacists,
community-based Clinical Nurse Specialists and Community Nurses) delivering end-of-life care in primary and
community care settings in England. Quantitative data were analysed using descriptive statistics.
Results: One thousand three hundred twenty-seven responses were received. All health professional groups are
engaged in supporting access to prescriptions, using a number of different methods. GPs remain a predominant
route for patients to access new prescriptions in working hours. However, nurses and, increasingly, primary care-
based pharmacists are also actively contributing. However, only 42% (160) of Clinical Nurse Specialists and 27% (27)
of Community Nurses were trained as prescribers. The majority (58% 142) of prescribing nurses and pharmacists did
not have access to an electronic prescribing system. Satisfaction with access to shared patient records to facilitate
medicines access was low: 39% (507) were either Not At All or only Slightly satisfied. Out-of-hours specialist cover
was reported by less than half (49%; 656) and many General Practitioners and pharmacists lacked confidence
advising about out-of-hours services. Respondents perceived there would be a significant improvement in pain
control if access to medicines was greater. Those with shared records access reported significantly lower pain
estimates for their caseload patients.
Conclusions: Action is required to support a greater number of nurses and pharmacists to prescribe end-of-life
medicines. Solutions are also required to enable shared access to patient records across health professional groups.
Coverage and awareness of out-of-hours services to access medicines needs to be improved.
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Background
Timely patient access to medicines during the last year of
life is essential for control of symptoms. Patients are com-
monly managing symptoms at home and may experience
extensive barriers to accessing essential medicines: our re-
cent study suggested prescription, dispensing, supply and
associated information given about medicines1 are diffi-
cult, complex, demanding, lack co-ordination, and involve
a multiplicity of professionals [1]. Problems were identi-
fied with each element of the access process – ranging
from the time-consuming nature of obtaining new pre-
scriptions, lack of pharmacy stock of medicines required,
to limited medicines information and misconceptions [1].
There is very limited research internationally on experi-
ences of accessing medicines for community palliative
care, but a few small studies are suggestive of problems.
Difficulties accessing medicines and medicines-related in-
formation, especially out-of-hours, were cited by both pal-
liative care service users and health care professionals in a
recent study of medication management for community
palliative care patients in Australia [2]. In a small study [3]
of 22 palliative care patients’ access to medicines in the
community in Ireland, multiple points of system failure
were found, including: patients unable to attend the Gen-
eral Practitioner (GP) (family doctor) for a prescription,
community nurse inability to contact GP for a prescrip-
tion, and lack of appropriate pharmacy stocks. Difficulties
and delays in accessing medicines is likely to adversely
affect symptom control, quality of life and use of un-
planned and out-of-hours services.
In England, community palliative care health services
are free at the point of delivery and may be offered to
patients living at home by either generalist and / or spe-
cialist health professionals. Generalists include the pa-
tient’s family doctor (General Practitioner), community
nurses who provide services for the General Practitioner
practice, community pharmacists (high street chemists)
and primary care-based pharmacists, working at the
General Practice site. Specialists include community-
based nurse specialists, who are either employed by a
local hospice or a local community or acute care Trust.
Recent national guidance in England on service delivery
for end-of-life care (in UK policy and practice this com-
monly equates to the last year of life [4]) recommends
the provision of multi-practitioner care, delivered by
those who have the skills and expertise to meet patient
needs, which includes access to medicines [4]. At the
same time, there are indications that sectors of the
workforce critical to palliative care prescribing, dispens-
ing, supply and early information-giving could be under-
utilised. UK legislation, in common with an increasing
number of other countries worldwide [5], permits nurses
and pharmacists who have undertaken the requisite pre-
scribing training course to prescribe medicines directly
to patients. But data suggest prescribing by specialist
palliative care nurses has not been exploited to its full
potential [6]. Little is known about why nurses’ roles in
prescribing in this area remain under-developed and
wider evidence about the impact on access to medicines
is lacking. In addition, community pharmacists’ - phar-
macists based in retail pharmacies or ‘chemist shops’ -
expertise in palliative care medicines optimisation has
been found to be under-utlilised [7, 8]. In England, com-
munity pharmacy palliative care medicines services have
been commissioned for a number of years; typically
these involve some pharmacies in a local area opting to
be paid by the National Health Service to stock a core
list of palliative care medicines and / or offer extended
opening hours for patients to access these medicines.
However, the impact of this initiative on access experi-
ences remains un-evaluated.
A small number of studies in the US [9–11] point to
the effectiveness of anticipatory prescribing kits in home
hospice care as a way of increasing timely patient access
to medicines in the home, but internationally, there is a
lack of research into how health professionals and differ-




As part of a larger study [12] our objective was to under-
take a large-scale survey to:
1. evaluate community-based health professionals’ in-
terventions to support patient access to medicines
2. identify the factors that influence health
professionals’ ability to support patient medicines
access
3. evaluate the extent to which the community-based
nurse and pharmacist workforce are engaged in in-
terventions to improve patient access to medicines
at end-of-life
4. elicit views on how effective professionals perceive
their service to be and what influences this
Design
An on-line questionnaire survey was designed using the
Checklist for Reporting Results of Internet E-Surveys
(CHERRIES) [13]. A systematic narrative review of inter-
national literature evaluating experiences, influences and
outcomes of medicines access associated with various
forms of delivering palliative care services informed
questionnaire design [12]. In light of the limited research
1We define ‘access’ as patient and / or carer ability to obtain medicines
from a prescriber and adispenser together with any information and
skills about medicines given at that point.
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in this area, we also consulted with clinical and academic
experts in the field to identify key issues. Both paper and
on-line versions of the questionnaire were piloted with
health professionals (total n = 19) inclusive of each of the
target groups: GPs, community nurses, clinical nurse spe-
cialists, primary care and community pharmacists. Minor
amendments were made in light of feedback. The final
questionnaire, administered via Online Surveys© (online-
surveys.ac.uk, Jisc), comprised sections including: roles in
access provision, in-hours and out-of-hours medicines
provision, inter-professional medicines communication,
nurse and pharmacist prescribing, and pain control levels
of patients - as a proxy to estimate perceived service ef-
fectiveness and factors influencing service effectiveness.
Items (1–3 per page) comprised closed-ended response
format, including Likert scales, and open-ended items (see
Supplementary File: ActMed questionnaire). Piloting indi-
cated that the questionnaire would take no longer than
approximately 10min to complete.
Sample
The target sample comprised representatives from the
main professional groups (generalist and specialist) pro-
viding community-based end-of-life care in England:
medical General Practitioners (GPs), pharmacists work-
ing in a community pharmacy (community pharmacists)
pharmacists who are employed part-time in GP practices
(primary care pharmacists), nurse specialists (Clinical
Nurse Specialists) in end-of-life care, and nurses (Com-
munity Nurses) delivering a range of care in patients’
homes, including palliative care.
Recruitment process and access
A survey website link was distributed via e-mail to GPs
and pharmacists via research leads employed as part of
local networks of research active GP practices and com-
munity pharmacists in England (National Institute for
Health Research Clinical Research Networks, which fund
and manage infrastructure to support the conduct of re-
search). Based on estimated numbers of health profes-
sionals in a typical Clinical Research Network and our
target response of 200 in each professional group, the
link was distributed to GPs in registered research active
General Practices in four Clinical Research Networks
(two in the north of England, two in the south), and to
pharmacists in all 15 Clinical Research Networks in Eng-
land. Distribution to pharmacists occurred via various
local pharmacist networks operating within the Clinical
Research Networks. Clinical leads for all hospices in
England with teams of Clinical Nurse Specialists deliver-
ing community-based palliative care (n = 146 /167 hos-
pices in England) distributed the survey via e mail to
their Clinical Nurse Specialist team, as did clinical leads
in seven community trusts (local community care
delivery organisations in England) that we identified em-
ploy Clinical Nurse Specialists directly. Based on esti-
mated numbers of Community Nurses in a typical
community trust, local collaborators in four community
trusts (two in northern, one in southern, and one in
eastern England) distributed the e-mail survey link to all
Community Nurses in the trust. In addition, the survey
link was posted on relevant interest groups’ websites and
in newsletters, for example, Association of Supportive
and Palliative Care Pharmacy, eHospice and the Associ-
ation for Prescribers. For GP practices, community phar-
macies and community trusts, organisational level
participation was captured via National Institute for
Health Research processes, which contributed to overall
payments to the Clinical Research Networks and to GP
practices who participated.
Patient and public involvement
The study research questions were derived from patient
experiences reported in our previous research [1] and
through consultation with local groups of palliative care
patients and unpaid carers caring for a family member
in the last year of life. The study team includes a Public
and Patient Involvement co-applicant, and the Study Sci-
entific Committee includes two Patient and Public In-
volvement members, whose views have helped shape the
survey questions. The study Patient and Public Involve-
ment representatives will all be offered a lay summary of
the study findings.
Data collection
Data were collected July – October 2018. Up to three re-
minders were distributed to maximize responses.
Analysis
Quantitative data were analysed using descriptive statis-
tics. For the analysis of the pain control data, we con-
ducted tests of differences in proportions comparing Q1
(current pain levels) and Q2 (estimated pain levels with
improvement to medicines access) responses. We also
created a weighted estimate from Q1 data (pain level es-
timates across a typical 100 end-of-life patients who use
your service) by multiplying the pain category (No = 0;
Mild = 1; Moderate = 2; Severe = 3) by the proportion of
individuals respondents estimated would be in those cat-
egories (thus, higher values represented higher levels of
pain). We then conducted linear regression with the
weighted variable as the dependent variable controlling
for the role of the respondent. Statistical analyses were
conducted using Stata®. A directed content analysis ap-
proach [14] was undertaken (NC and JB) to analyse free
text responses, including quantification.
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Results
Respondents
A total of 1327 responses from eligible healthcare pro-
fessionals were received: 499 GPs, 389 Clinical Nurse
Specialists, 219 community pharmacists, 151 primary
care pharmacists (30 were employed as both community
pharmacists and primary care pharmacists) and 99 Com-
munity Nurses. Missing data were very low (< 1% for the
majority of questions); all responses provided were used
(i.e., no case-wise deletion) and no imputation was car-
ried out. All percentages are calculated from responses
provided (i.e. excluding missing data).
Medicines access practices
Methods of providing new prescriptions in-hours
Access routes to new prescriptions for palliative care medi-
cines during working hours are shown in Table 1. (These
medicines were defined as regular and as necessary medi-
cines, administered via all routes for symptom management
during the last year of life (excluding ‘Just in Case’ boxes2)).
Most nurses and GPs were providing home visits for pa-
tients to obtain new prescriptions, high numbers of all pro-
fessional groups were also providing consultations by
telephone, and a significant minority also reported using e-
mail. Over 93% of all professional groups used referral to a
GP as a route for patients to access medicines; large propor-
tions of all professionals also cited referral to a nurse pre-
scriber. Table 1 also shows a relatively high level of
engagement in helping to provide new scripts by primary
care pharmacists. 52% (79) of the primary care pharmacist
sample also reported advising patients / carers about pallia-
tive care medicines (43% (65) did not) and 63% (95) reported
engagement in systematically reviewing medicines prescribed
for palliative care patients (32% (49) did not).
Overall, many respondents were satisfied with their
ability to support patients to obtain new prescriptions
during working hours: 57% (762) were Extremely or
Very Satisfied, especially GPs (77% 386); however, 43%
(567) of the sample were Somewhat, Slightly or Not At
All Satisfied.
Nurse and pharmacist prescribing
Of nurse and pharmacist respondents, 42% (160) of
Clinical Nurse Specialists, 27% (27) of Community
Nurses, 76% (114) of primary care pharmacists and 16%
(36) of community pharmacists were qualified as Inde-
pendent Prescribers. The most common reasons for not
training as a prescriber were the cost of training (31%
155), lack of employer / colleague support (24% 122), no
backfill of their post available whilst attending training
(18% 92) and no designated clinically-based trainer avail-
able (16% 80), which is a requirement for UK nurse and
pharmacist prescriber trainees.
Of the nurse and pharmacist respondent groups, Clin-
ical Nurse Specialists prescribed most frequently, with
two thirds (66%; 86) prescribing at least 2–3 times per
week, whereas two thirds (64%; 14) of the Community
Nurses, primary care pharmacists (69%; 60) and commu-
nity pharmacists (60%; 12) only prescribed once per
month or less. Analgesics, anti-emetics and laxatives
were identified as the most frequently prescribed medi-
cines by all of the nurse and pharmacist prescriber pro-
fessional groups. For all respondent groups, the majority
(84% 206) prescribed Controlled Drugs (controlled sub-
stances), ranging from 96% (125) of Clinical Nurse Spe-
cialists to 69% (60) of primary care pharmacists.
The majority (58% 142) of prescribing nurses and
pharmacists were not able to use an electronic pre-
scribing system (whereby details of prescribed medi-
cine/s are entered electronically and where scripts can
be sent direct to a pharmacy for dispensing to the pa-
tient) (Table 2).
Table 1 Routes provided for access to new prescriptions during working hours












Personal home visits 349 (92) 82 (93) 484 (98) 52 (43) 49 (35)
Telephone consultations 335 (88) 78 (91) 498 (100) 134 (96) 147 (85)
Email consultations 79 (24) 8 (10) 169 (35) 32 (28) 63 (43)
GP practice appts. 168 (51) 43 (56) 496 (100) 122 (91) 44 (38)
Community pharmacy appts. 37 (12) 11 (15) 118 (29) 28 (29) 131 (73)
Referral to nurse prescriber 194 (58) 69 (78) 286 (65) 102 (78) 101 (62)
Referral to pharmacist prescriber 64 (20) 21 (26) 149 (34) 66 (65) 81 (53)
Referral to GP 375 (97) 92 (96) 351 (95) 147 (100) 185 (93)
Percentages calculated as those responding yes out of those applicable (i.e., discounting NAs)
NOTE: different numbers of “NA” recorded throughout so percentages have different denominators
Key: CNS Clinical Nurse Specialist, CN Community Nurse, GP General Practitioner, PCP Primary Care Pharmacist, CP Community Pharmacist
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The vast majority of Clinical Nurse Specialist prescribers
in particular, were restricted to writing prescriptions by
hand via a paper prescription pad only. Only a minority of
all respondent groups were able to prescribe electronically
and transfer this electronically to the pharmacy.
Out-of-hours services for medicines access
Asked if there was Clinical Nurse Specialist service
provision 7 days a week in their area, overall 49% (656)
responded Yes, 18% (239) stated No provision and 33%
(424) were not aware whether there was provision or
not. Of note, 76% (166) of community pharmacists, 72%
(109) of primary care pharmacists and 33% (167) of GPs
were not aware. 20% (76) of Clinical Nurse Specialist re-
spondents reported covering 6.30 pm-8.00 am weekdays
and 71% (276) reported covering weekends and Bank
Holidays; for Community Nurses, cover was 43% (43)
and 67% (66) respectively.
Respondents were also asked how effective Clinical Nurse
Specialist 7 days a week cover was at facilitating out-of-hours
access to medicines for patients. Overall, 43% (280) rated
Clinical Nurse Specialist cover as Extremely or Very Effect-
ive; 36% (235) reported Somewhat and 22% (141) only
Slightly or Not At All effective. Analysis of comments indi-
cated that Clinical Nurse Specialists’ ability to prescribe med-
icines seemed to be critical in their perceived effectiveness,
and, for some, this also interacted with access to pharmacy
stocks to influence speed of access.
Asked about confidence in their ability to advise pa-
tients how to best access palliative care medicines out-
of-hours, nurses – in particular Clinical Nurse Special-
ists– tended to rate themselves as most confident. 79%
(307) of Clinical Nurse Specialists were Extremely or
Very confident, as were 61% (61) of Community Nurses.
Pharmacists were less confident, with 30% (45) of pri-
mary care pharmacists and 39% (86) of community
pharmacists rating themselves as Extremely or Very
confident. Although 47% (236) of GPs reported being
Extremely or Very confident, 35% (177) were only Some-
what confident and 18% (86) were Slightly or Not At All
confident.
Community pharmacy commissioned service provision
Table 3 shows the provision of commissioned palliative
care medicines services by community pharmacist re-
spondents (n = 219).
The vast majority of services included stocking a core
list of agreed palliative care medicines; a smaller propor-
tion – approximately half – reported providing out-of-
hours medicines from their own pharmacy and 28% (19)
via a linked pharmacy in their area. Around two thirds
of the sample reported providing information on the ser-
vice to health care professionals (70% 47) and directly to
patients and carers (61% 41).
Asked whether they were aware of commissioned ser-
vices for palliative care medicines, overall 39% (517) of
all healthcare professionals stated Yes, 9.2% (122) re-
ported No Provision and 52% (690) were Unaware. GPs
in particular lacked awareness (68%; 340). However,
where respondents were aware, the vast majority (84%
433) considered that the service facilitates speed of ac-
cess to medicines for patients.
Factors influencing medicines access service provision
Prescribing competence
Overall, just under two thirds (64% 518) of the sample
reported feeling Very (46% 373) or Extremely (18% 145)
competent in prescribing palliative care medicines, with
27% (217) feeling Somewhat, and 10% (84) reporting
Slightly or Not At All competent. Clinical Nurse Special-
ist respondents reported greatest competence, with 84%
(132) feeling Very or Extremely competent; 70% (347) of
GPs reported feeling Very or Extremely competent, with
almost one third (29% 142) rating themselves as Some-
what competent. Over one third (40% 10) of Community
Nurses reported feeling Very or Extremely competent,
with 48% (12) reporting they were Somewhat competent.
Pharmacists reported less competence: 22% (24) of pri-
mary care pharmacists and 14% (7) of community phar-
macists reported feeling Extremely or Very competent.
Access to patient records
Experience of access to shared patient records for com-
municating about medicines is shown in Table 4.
Data revealed a variable picture: those based in GP
practice (GPs and primary care pharmacists) had rela-
tively high levels of access. However, Clinical Nurse Spe-
cialists in particular reported limited access to others’
records, whether paper or electronic: 44% (173) reported
no access to GP records and 66% were unable to access
GP out-of-hours records.
2A number of standard medicines prescribed in advance - often in a
specially marked container - specifically for the last days of life.
Table 2 Nurses’ and pharmacists’ ability to prescribe
electronically




















Yes – with transfer to
pharmacy




Yes – no transfer to
pharmacy
28 (11) 6 (4.6) 4 (18) 2 (2.3) 5 (25)
Key: CNS Clinical Nurse Specialist, CN Community Nurse, GP General
Practitioner, PCP Primary Care Pharmacist, CP Community Pharmacist
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Satisfaction with access to shared records to facilitate
medicines access reflected these results: 39% (507) of re-
spondents overall were either Not At All or only Slightly
satisfied. Clinical Nurse Specialists and community phar-
macists were especially likely to rate access as Not At
All satisfactory, with half of all Clinical Nurse Specialists
(50% 193) reporting that they were either Not At All or
only Slightly satisfied.
Impact of nurse and pharmacist prescribing
Overall, just over half of respondents considered that
prescribing by a nurse or pharmacist consistently had a
beneficial impact on palliative care medicines access: Al-
ways 21% (283) or Often (34% 445). However, a quarter
of GPs (25% 124), 29% (44) primary care pharmacists
and 26% (58) of community pharmacists reported that
they did not know about the impact of this initiative on
access to medicines, with comments reflecting their lack
of, or limited experience of these services.
Community pharmacy provision of palliative medicines
Table 5 shows the results of community pharmacist re-
spondents’ opinions on issues identified in our review of
the literature which may potentially impact their ability
to facilitate access to medicines, confirming that a num-
ber of issues were problematic in practice.
Analysis of comments from 703 respondents to open-
ended items on service delivery solutions highlighted the
most frequently cited were: better community and pri-
mary care pharmacy provision (173/703); more nurse
and pharmacist prescribers (162/703); shared electronic
records (148 /703); and integrated working (145/703).
Table 4 Access to patient records
Do you have access to shared patient records for communication about medicines access between health professionals? Tick all that you
are able to access:



































































































































































aFor those classed as only primary care pharmacists (i.e., not primary care and community pharmacist)
Key: CNS Clinical Nurse Specialist, CN Community Nurse, GP General Practitioner, PCP Primary Care Pharmacist, CP Community Pharmacist, Elec Electronic, No None,
OOH Out-of-Hours
Table 3 Provision of commissioned community pharmacy palliative care medicines services
If you are a community pharmacist in a community pharmacy, do you provide an enhanced service for palliative care (e.g. on-demand
availability of specialist drugs)?
Yes No
Commissioned servicea 67 (31) 148 (68)
Of those with a commissioned service
Stocking a locally agreed list of core palliative care medicines 62 (93) 5 (7.5)
OOH availability of palliative care medicines from your pharmacy 32 (48) 35 (52)
OOH availability of palliative care medicines from other linked pharmacies in your area 19 (28) 48 (72)
Provision of info on the service to other pharmacy contractors and HCPs to signpost patients to the service 47 (70) 20 (30)
Provision of info on the service to patients and carers directly 41 (61) 26 (39)
aFour (4; 1.8%) missing
Key: OOH Out-of-hours, HCPs Health Care Professionals
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Perceived effectiveness of service and impact of barriers
Respondents were asked to estimate the proportion of
their patients who currently experienced No, Mild, Mod-
erate and Severe pain (Q1), and then to re-estimate
these proportions following removal of barriers to medi-
cines access (Q2). Figure 1 shows that there would be a
significant perceived improvement in pain control with
better medicines access (No Pain p = .0018; Mild Pain
p = NS; Moderate Pain p = .026; Severe Pain p = .047).
However, missing data for these questions was higher than
for other items (18 and 23% respectively) and a further 10%
for both provided invalid answers (that did not sum to 100).
There was a clear impact of respondent role in Q1 and
Q2 data with pharmacists indicating they see higher pro-
portions of patients with poor pain control. This was
likely an artefact of ‘casemix’ or patients / their family
carers who present to pharmacists, rather than service
effectiveness. We tested the impact of various service
factors on weighted Q1 response. After controlling for
role there were few statistically significant predictors of
pain control outcomes. However, respondents within
services with access to GP records or Summary Care Re-
cords (an electronic record of patient information, cre-
ated from GP medical records which can be seen and
used by authorised staff in other areas of the health and
care system involved in the patient’s direct care in Eng-
land) [15] reported significantly lower pain estimates
(p = .005 and p = .009 respectively).
Discussion
Main findings
This first large-scale survey of healthcare professionals
providing palliative care to patients in the community in
England captured views on medicines access and
highlighted current practices and factors that operate to
support or hinder access. Furthermore, although only in-
dicative, our results provide evidence of the impact of
access to medicines on patient outcomes (level of pain
control in the example given).
GPs remain a predominant route for patients to access
new prescriptions in working hours. However, nurses
and, increasingly, primary care-based pharmacists are
also actively contributing. This diversification of skill
mix reflects a national policy drive to increase the range
of healthcare professionals delivering primary care [16],
including multi-practitioner palliative care [4].
However, our survey confirms there is potential to in-
crease the numbers of nurses trained to prescribe pallia-
tive care medicines for patients, in particular Clinical
Nurse Specialists. Less than half of Clinical Nurse Spe-
cialists surveyed were trained as prescribers, with costs
and workplace support cited as inhibitory. Their poten-
tial to increase medicines access at end-of-life is clear
from our results which show that, when trained as pre-
scribers, Clinical Nurse Specialists were prescribing
Table 5 Issues influencing community pharmacy palliative medicines provision
How frequently do you:
Never Rarely Sometimes Often Always





















































Responses range n = 215 to n = 217
Fig. 1 Mean proportions across pain category for current and
improved medicines access
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often, including controlled drugs, considered themselves
highly competent, and were perceived by many as very
effective at speeding patients’ access to medicines. Incen-
tives are needed and barriers preventing training in this
competency need to be removed in order to effectively
support them, and perhaps also Community Nurses, to
train to prescribe medicines. Such support should cer-
tainly include enabling all prescribing community-based
nurses to utilise electronic prescribing systems, to speed
safe prescription-writing and dispensing processes.
Internationally, the role of the pharmacist in the
provision of health care in the community is growing
rapidly, driven by GP workforce shortages and increasing
population need [17]. Whilst many primary care phar-
macists in our survey were trained to prescribe medi-
cines and advising on and reviewing medicines with
end-of-life patients, most did not feel competent pre-
scribing in this area and prescribed infrequently. Whilst
this self-selecting survey sample may over-represent en-
gagement of primary care pharmacists in end-of-life
provision, for those who are involved, being competent
to manage palliative care medicines may provide patients
with a further route to access the right medicines in a
timely way, especially given primary care pharmacists’
level of access to shared records. In light also of the
mixed levels of palliative care prescribing competence
expressed by GPs in our survey, in line with others’ rec-
ommendations [18], this suggests a need for more training
and / or support from palliative care specialists to under-
pin safe and confident prescribing for patients in the com-
munity. Education in end-of-life issues is crucial for the
large number of doctors for whom end-of-life care is not
the sole component of their work, but who play a signifi-
cant role in caring for this group of patients [19].
National guidelines in England on end-of-life care rec-
ommend people and their carers should have access out-
of-hours to a pharmacy service with medicines for symp-
tom control [4]. Despite its positive evaluation by many
in our survey, several factors are inhibiting the full po-
tential of currently commissioned community pharmacy
palliative care medicines services. Many lacked aware-
ness of the service, and most services provided did not
include access to medicines out-of-hours. Many pharma-
cists were not aware of patients’ palliative care status
and stock issues also detracted from their ability to pro-
vide medicines to patients in a timely way. In line with
others’ recommendations [20, 21], closer integration and
better communication between community pharmacists
and palliative care service providers is required to ad-
dress such barriers, including for example, allowing
community pharmacists access to palliative care registers
of patients held locally by GPs [21].
A further, widespread barrier to the provision of swift
and timely access to medicines in this context concerned
a lack of shared access to patient records through which
to communicate about medicines, especially for those
outside of GP practice systems. Our survey respondents
reported high levels of dissatisfaction with this aspect of
service delivery. Access to patient records was also found
to be the main determinant of services’ effectiveness on
pain control. Prescribing will be delayed if the prescriber
is not able to access patients’ clinical history and medi-
cations, thus potentially inhibiting symptom control and
increasing patient and carer distress. To avoid out-of-
hours medication safety incidents, Williams et al. (2018)
[22] recommend communication solutions to enable pri-
mary care team members to collaborate effectively –
such as encrypted end-to-end messaging systems em-
bedded within the clinical record system – to allow ap-
propriate plans for symptom relief to be coherently
developed. Given the emphasis in recent national guid-
ance [4] on multi-practitioner care, care co-ordination
and health care professionals who can access patient re-
cords 24 h a day, 7 days a week, this lack of shared re-
cords access requires urgent attention.
Strengths and limitations
To our knowledge, this is the first large scale survey
internationally to provide data about healthcare profes-
sionals’ practices and views on the critical issue of how
they currently provide access to medicines for palliative
care patients in the community. As this was an on-line
survey, we were not able to calculate response rates;
however, our target numbers of respondents were
exceeded in all but the Community Nurse group. We
have no reason to suspect Clinical Nurse Specialist and
community pharmacist samples were not nationally geo-
graphically spread. Survey respondents were assured of
anonymity and we stressed our interest included under-
standing challenges and barriers, to encourage honest
answers. Nevertheless, GP, primary care pharmacists,
community pharmacist and Community Nurse respon-
dents may have had a special interest in palliative care
and therefore have atypical practices or views. The large
sample size and low rate of missing data gives some re-
assurance that the conclusions of the study are not un-
duly affected by missing responses; however, there were
notably higher rates of missing data for the questions on
perceived effectiveness.
Conclusions
Results show that a range of healthcare professionals
and routes are currently being used to support patient
access to palliative care medicines, but there is potential
to increase the scale and effectiveness of these through
addressing the barriers highlighted in this paper. These
include increasing the competence of existing pre-
scribers, training greater numbers of the community
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nurse workforce to prescribe using electronic systems, as
well as ensuring better access to patient records across
professional groups. This needs to take place alongside
attention to out-of-hours service delivery, including im-
proved awareness amongst GPs and pharmacists of
existing service provision and tackling the impediments
that currently reduce the effective provision of commu-
nity pharmacy commissioned medicines services.
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